Profil
Jean-Yves Blay is currently an Independent Director at Transgene SA since 2022 and General Director at Centre Léon Bérard Lyon et Rhône-Alpes since 2014.
Former positions include Independent Member-Supervisory Board at Innate Pharma SA from 2017 to 2025, President of the European Organisation for Research & Treatment of Cancer from 2009 to 2012, Secretary of the Oncology Commission at Académie Nationale de Médecine FCP, and President of UNICANCER from 2019 to 2022.
Education includes a doctorate from Université Claude Bernard Lyon 1, conferred in 1994.
Aktiva positioner av Jean-Yves Blay
| Företag | Position | Start |
|---|---|---|
| TRANSGENE | Direktör/Styrelseledamot | 2022-05-25 |
Centre Léon Bérard Lyon et Rhône-Alpes | Verkställande Direktör | 2014-01-01 |
Tidigare kända positioner av Jean-Yves Blay
| Företag | Position | Slut |
|---|---|---|
| INNATE PHARMA | Direktör/Styrelseledamot | 2025-05-22 |
UNICANCER
UNICANCER Hospital/Nursing ManagementHealth Services Operates as cancer center | President | 2022-01-01 |
European Organisation for Research & Treatment of Cancer
European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization | President | 2012-01-01 |
Académie Nationale de Médecine FCP
Académie Nationale de Médecine FCP Miscellaneous Commercial ServicesCommercial Services Operates as professional organization for medicine | Företagsledare/Principal | - |
Jean-Yves Blays utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Université Claude Bernard Lyon 1
Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centre Léon Bérard Lyon et Rhône-Alpes | |
European Organisation for Research & Treatment of Cancer
European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization | Commercial Services |
Académie Nationale de Médecine FCP
Académie Nationale de Médecine FCP Miscellaneous Commercial ServicesCommercial Services Operates as professional organization for medicine | Commercial Services |
UNICANCER
UNICANCER Hospital/Nursing ManagementHealth Services Operates as cancer center | Health Services |
















